Autoimmune Hemolytic Anemia and Its Clinical Implication on Antiphospholipid Syndrome

Recruiting now · Not applicable

Conditions studied: Anti Phospholipid Syndrome

In brief

AIHA is a heterogeneous autoimmune cytopenia with variable severity and significant morbidity. APS is defined by thrombosis and/or obstetric morbidity with persistent antiphospholipid antibodies (aPL).

Key facts

Study ID

NCT07743242

Run by

New Valley University

People needed

230

Starts

2026-06-05

Expected to finish

2028-04-15

Last updated by the study team

2026-08-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged ≥18 years
• Patients with anemia consistant with hemolysis.
• Patient diagnosed with antiphospholipid syndrome.
• Informed consent obtained

You may not qualify if…

• Age less than 18 years.
• Other causes of anemia than autoimmune hemolysis.

Where it is running

• New Valley University — Al Khārjah, Kharga Oasis, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.